Liraglutide.
Journal: 2010/June - Nature Reviews Drug Discovery
ISSN: 1474-1784
Abstract:
In January 2010, liraglutide (Victoza; Novo Nordisk)--an injectable glucagon-like peptide 1 receptor agonist--was approved by the US FDA to improve glycaemic control in adults with type 2 diabetes mellitus.
Open in
PUBMED | DOI | Google Scholar | Wikipedia
Relations:
Citations
(33)
References
(14)
Diseases
(1)
Chemicals
(3)
Organisms
(1)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.